📖Complete Guide✅Updated 2026🔬Evidence-Based
KPV Guide (2026)
Complete Guide & Evidence (2026)
Alpha-MSH tripeptide fragment with potent anti-inflammatory action. Oral bioavailability for gut inflammation (IBD, IBS).
Dashboard
Your complete health overview in one place
🔥
14-day streak
Logged 18 of 18 scheduled shots
Medication Supply
Kpv
~42 days left · Mar 15
B12
~88 days left · May 8
Retatrutide
~6 days left · refill soon
Medication Levels
7 Days2 Weeks1 Month90 Days
CURRENT LEVEL
5.42mg
Mar 6
Today
ACTIVE MEDICATIONS
KpvRetatrutide
0mg2.7mg5.4mg
18
Total Injections
💉 All time
122/78
Average BP
🩺 mmHg
8.4
Avg Mood
😊 /10
Health Chart
1mAll
218.6lb
↓ 8.4 lb · 3.7%
WeightInjectionsBPMood
Feb 6Feb 14Feb 22Mar 2Today
Photos
12 photos · 2w streak
Week 1
Week 7
Today
Scheduled Reminders
Weight
Due today
Mood
Done
Blood Pressure
Tomorrow
Body Measurements
In 3 days
Dashboard
Your complete health overview in one place
🔥
14-day streak
Logged 18 of 18 scheduled shots
Medication Supply
Kpv
~42 days left · Mar 15
B12
~88 days left · May 8
Retatrutide
~6 days left · refill soon
Medication Levels
7 Days2 Weeks1 Month90 Days
CURRENT LEVEL
5.42mg
Mar 6
Today
ACTIVE MEDICATIONS
KpvRetatrutide
0mg2.7mg5.4mg
18
Total Injections
💉 All time
122/78
Average BP
🩺 mmHg
8.4
Avg Mood
😊 /10
Health Chart
1mAll
218.6lb
↓ 8.4 lb · 3.7%
WeightInjectionsBPMood
Feb 6Feb 14Feb 22Mar 2Today
Photos
12 photos · 2w streak
Week 1
Week 7
Today
Scheduled Reminders
Weight
Due today
Mood
Done
Blood Pressure
Tomorrow
Body Measurements
In 3 days
01WHAT TO TRACK
How KPV Works
01
🔬
NF-κB Inhibition
Directly blocks the master inflammatory switch. Reduces TNF-α, IL-1β, IL-6 expression. Faster anti-inflammatory onset than full α-MSH
02
🔬
Oral Bioavailability
Resists gastric acid degradation. Reaches intestinal epithelium intact. Ideal for IBD, IBS, Crohn's protocols
03
✨
Skin & Wound Action
Reduces cutaneous inflammation via MC1R. Accelerates wound closure in vitro. Topical formulations for eczema, psoriasis
02BACKGROUND
Key Research Snapshots
Reduction in TNF-α in murine colitis models vs. vehicle control.
Typical daily oral dose studied in gut-inflammation research protocols.
Estimated plasma half-life after subcutaneous administration in animal studies.
04WHAT TO TRACK
Safety & Side Effects
01
🔬
Mild / Transient
Injection site redness (subcutaneous). Mild GI upset at high oral doses. Rare: fatigue during initial use
02
⚠️
Safety Profile
No hepatotoxicity reported in animal studies. No hormonal effects unlike full α-MSH. Well-tolerated at standard research doses
05WHAT TO TRACK
Vital Protocol FAQs
01
🔬
What is KPV peptide?
KPV (Lys-Pro-Val) is a tripeptide fragment of alpha-MSH (alpha-melanocyte-stimulating hormone) that carries its anti-inflammatory activity. It directly inhibits NF-κB signaling and pro-inflammatory cy
02
💉
What dose of KPV is typically used?
For gut conditions, oral KPV is typically used at 200–500 mcg per day because it resists digestion and reaches the intestinal epithelium intact. For subcutaneous protocols, 200–300 mcg/day is commonly
03
🌿
Is KPV safe for the gut?
Preclinical studies show KPV reduced colitis severity in mouse models of IBD by decreasing neutrophil infiltration and pro-inflammatory cytokines. Human data is limited to case reports and small serie
04
🧬
How does KPV compare to BPC-157 for gut healing?
KPV and BPC-157 address gut inflammation via different pathways. KPV blocks NF-κB and cytokine signaling directly; BPC-157 promotes angiogenesis and growth factor upregulation for mucosal repair. Many
06FAQ
Guide FAQs
Alpha-MSH tripeptide fragment with potent anti-inflammatory action. Oral bioavailability for gut inflammation (IBD, IBS).
Yes. Shotlee supports tracking Kpv doses, side effects, and health metrics. It is free to use.
Free · Always
Track Your Kpv Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.